Roche is narrowing its pipeline to 11 disease areas and continuing to invest in a targeted way, said Teresa Graham, chief ...

Tolerability issues for CT-388 and CT-996 may impact Roche Holdings AG, but strong pipeline prospects remain. Discover why ...

Severin Schwan criticized the subsidies that the U.S. and European governments are using to boost their manufacturing ...

Maybe you should dial back your training for better performance.

Roche is rolling out what it describes as a new type of infectious disease diagnostic in Europe, with a single test capable ...

Swiss drug major Roche Group (RHHBY) announced Tuesday the launch of the cobas Respiratory flex test, the first to use Roche's novel ...

Roche said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its ...

Roche Holding's chairman criticizes industrial subsidies as wasteful, advocating for fair competition and government ...

Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

Roche Holdings AG (OTC:RHHBY) released positive topline results of the phase 3 CENTERSTONE study of Xofluza (baloxavir ...

Roche Holding AG said side effects in a highly anticipated study of its experimental obesity pill were milder when it eased ...